| |
| |
|
| Insider
Information: |
Taylor Beth |
| Relationship: |
Chief Financial Officer |
| City: |
West Lafayette |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
94,792 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$404,762 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
94,792 |
|
|
| Total
Value |
$404,762 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.0
|
0.0
|
| Percentage
Gain/Loss : |
 168.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endocyte Inc |
ECYT |
VP Finance & Chief Acc... |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
|
Inotiv Ord Shs |
NOTV |
Chief Financial Officer |
2023-02-17 |
94,792 |
2020-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
35 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ECYT |
Endocyte Inc |
Corporate ControllerOfficer |
• – – |
2011-05-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,722 |
|
- |
|
| ECYT |
Endocyte Inc |
Corporate Controller |
• – – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,425 |
7,147 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Corporate Controller |
• – – |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
12,152 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Corporate Controller |
• – – |
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
17,007 |
0 |
- |
|
| ECYT |
Endocyte Inc |
VP Finance & Chief Acctg Offcr |
• – – |
2016-08-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
21,283 |
0 |
- |
|
| ECYT |
Endocyte Inc |
VP Finance & Chief Acctg Offcr |
• – – |
2017-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
31,283 |
0 |
- |
|
| ECYT |
Endocyte Inc |
VP Finance & Chief Acctg Offcr |
• – – |
2017-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
61,283 |
0 |
- |
|
| ECYT |
Endocyte Inc |
VP Finance & Chief Acctg Offcr |
• – – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
71,540 |
0 |
- |
|
| ECYT |
Endocyte Inc |
VP Finance & Chief Acctg Offcr |
• – – |
2018-12-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,250 |
1,250 |
0 |
- |
|
| ECYT |
Endocyte Inc |
VP Finance & Chief Acctg Offcr |
• – – |
2018-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,750 |
101,445 |
0 |
- |
|
| ECYT |
Endocyte Inc |
VP Finance & Chief Acctg Offcr |
• – – |
2018-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,186 |
98,259 |
0 |
- |
|
| NOTV |
Inotiv Ord Shs |
VP- Finance & CFO |
• – – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
23,300 |
0 |
- |
|
| NOTV |
Inotiv Ord Shs |
VP- Finance & CFO |
• – – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
880 |
35,175 |
0 |
- |
|
| NOTV |
Inotiv Ord Shs |
VP- Finance & CFO |
• – – |
2021-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,332 |
38,661 |
0 |
- |
|
| NOTV |
Inotiv Ord Shs |
VP- Finance & CFO |
• – – |
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
214 |
38,875 |
0 |
- |
|
| NOTV |
Inotiv Ord Shs |
VP- Finance & CFO |
• – – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
78,875 |
0 |
- |
|
| NOTV |
Inotiv Ord Shs |
Chief Financial Officer |
• – – |
2023-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,917 |
89,792 |
0 |
- |
|
| NOTV |
Inotiv Ord Shs |
Chief Financial Officer |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
94,792 |
0 |
- |
|
| ECYT |
Endocyte Inc |
VP Finance & Chief Acctg Offcr |
• – – |
2018-12-17 |
4 |
OE |
$2.16 |
$210,509 |
D/D |
48,854 |
105,195 |
0 |
- |
|
| ECYT |
Endocyte Inc |
VP Finance & Chief Acctg Offcr |
• – – |
2018-02-06 |
4 |
D |
$3.00 |
$1,452 |
D/D |
(484) |
59,040 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Corporate Controller |
• – – |
2016-02-06 |
4 |
D |
$3.02 |
$1,586 |
D/D |
(525) |
16,482 |
0 |
- |
|
| ECYT |
Endocyte Inc |
VP Finance & Chief Acctg Offcr |
• – – |
2018-02-02 |
4 |
D |
$3.12 |
$2,777 |
D/D |
(890) |
60,393 |
0 |
- |
|
| ECYT |
Endocyte Inc |
VP Finance & Chief Acctg Offcr |
• – – |
2018-02-04 |
4 |
D |
$3.12 |
$2,711 |
D/D |
(869) |
59,524 |
0 |
- |
|
| NOTV |
Inotiv Ord Shs |
VP- Finance & CFO |
• – – |
2020-05-19 |
4 |
B |
$4.38 |
$22,193 |
D/D |
5,067 |
5,067 |
2.74 |
% |
|
| NOTV |
Inotiv Ord Shs |
VP- Finance & CFO |
• – – |
2020-05-20 |
4 |
B |
$4.42 |
$21,804 |
D/D |
4,933 |
10,000 |
2.74 |
% |
|
35 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
